PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation
BLOOD CELL THERAPY / The official journal of APBMT · 2025 · 8 (2)
DOI: 10.31547/bct-2024-034 ↗Kurz gefasst
Fachartikel in der Zeitschrift BLOOD CELL THERAPY / The official journal of APBMT, 2025. Verfasst von Ling Ma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital and Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing…. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Peking University People's Hospital and Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, C…
Zitieren
APA
Ma, L., Li, S. Q., Han, W., Fu, H. X., Chen, Y., Ma, R., Chen, Y. H., Zhang, X. H., Xu, L. P., Wang, Y., Yan, C. H., Wang, F. R., Mo, X. D., Huang, X. J., & Sun, Y. Q. (2025). PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation. BLOOD CELL THERAPY / The official journal of APBMT, 8(2). https://doi.org/10.31547/bct-2024-034
Vancouver
Ma L, Li SQ, Han W, Fu HX, Chen Y, Ma R, et al. PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation. BLOOD CELL THERAPY / The official journal of APBMT. 2025;8(2). doi:10.31547/bct-2024-034
BibTeX
@article{Ma2025,
author = {Ma, Ling and Li, Si-Qi and Han, Wei and Fu, Hai-Xia and Chen, Yao and Ma, Rui and Chen, Yu-Hong and Zhang, Xiao-Hui and Xu, Lan-Ping and Wang, Yu and Yan, Chen-Hua and Wang, Feng-Rong and Mo, Xiao-Dong and Huang, Xiao-Jun and Sun, Yu-Qian},
title = {PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation},
journal = {BLOOD CELL THERAPY / The official journal of APBMT},
year = {2025},
volume = {8},
number = {2},
doi = {10.31547/bct-2024-034}
}
EUVIMED